Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen McMahon

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Health Law in Canada|December 10, 2009
Canada proposes amendments to adverse drug reaction reportingEileen McMahon, Teresa Reguly
Health Law in Canada|January 21, 2012
Canada's approach to functional foodsEileen McMahon, Teresa Reguly
The Journal of Biolaw & Business|March 17, 2006
Stem cell research in Canada: business opportunities for U.S. companiesCheryl Reicin, Eileen McMahon
Health Law in Canada|August 26, 2009
Data protection for " innovative drugs"--guidance now finalEileen McMahon, Teresa Reguly
Health Law in Canada|December 10, 2009
Promotion of drugs and devices at international conferences held in CanadaEileen McMahon, Laila Paszti
Nursing Science Quarterly|April 2, 2005
The language of loss when a baby dies prior to birth: cocreating human experienceChristine Jonas-Simpson, Eileen McMahon
Nursing|October 22, 2013
AnaphylaxisVincent M Vacca, Eileen McMahon-Bowen
Health Law in Canada|August 23, 2012
Canada to change the regulation of "food-like" natural health productsEileen McMahon, Ingrid VanderElst, Teresa Reguly, et al.
BMJ Case Reports|April 30, 2017
βhCG-secreting osteosarcomaEmily Harrold, Eileen McMahon, Peadar McGing, et al.
F&S Reports|March 24, 2023
Timing of testosterone discontinuation and assisted reproductive technology outcomes in transgender patients: a cohort studyMohammad Albar, Alex Koziarz, Eileen McMahon, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Health Law in Canada|December 10, 2009
Canada proposes amendments to adverse drug reaction reportingEileen McMahon, Teresa Reguly
Health Law in Canada|January 21, 2012
Canada's approach to functional foodsEileen McMahon, Teresa Reguly
The Journal of Biolaw & Business|March 17, 2006
Stem cell research in Canada: business opportunities for U.S. companiesCheryl Reicin, Eileen McMahon
Health Law in Canada|August 26, 2009
Data protection for " innovative drugs"--guidance now finalEileen McMahon, Teresa Reguly
Health Law in Canada|December 10, 2009
Promotion of drugs and devices at international conferences held in CanadaEileen McMahon, Laila Paszti
Nursing Science Quarterly|April 2, 2005
The language of loss when a baby dies prior to birth: cocreating human experienceChristine Jonas-Simpson, Eileen McMahon
Nursing|October 22, 2013
AnaphylaxisVincent M Vacca, Eileen McMahon-Bowen
Health Law in Canada|August 23, 2012
Canada to change the regulation of "food-like" natural health productsEileen McMahon, Ingrid VanderElst, Teresa Reguly, et al.
BMJ Case Reports|April 30, 2017
βhCG-secreting osteosarcomaEmily Harrold, Eileen McMahon, Peadar McGing, et al.
F&S Reports|March 24, 2023
Timing of testosterone discontinuation and assisted reproductive technology outcomes in transgender patients: a cohort studyMohammad Albar, Alex Koziarz, Eileen McMahon, et al.
Pageof 3